IPAH can significantly impact reproductive health and fertility. Women with IPAH may experience menstrual irregularities and decreased ovarian reserve due to chronic hypoxia. Additionally, the medications used to manage IPAH, such as endothelin receptor antagonists and phosphodiesterase-5 inhibitors, can have teratogenic effects, complicating the decision to conceive.
